Andrea Charles | 06/18/2013
In this interview Christine Brideau, Executive Director, Biological Sample Management at Merck, speaks to Andrea Charles from Pharma IQ, about how biological sample management is now being addressed in the discovery space and the lack of retention policies for biological samples. Brideau also shares her top tips for establishing a consistent and holistic management system for biological samples and discusses the importance of risk reduction and emergency preparedness....
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
SmartLab Exchange USA
April 20-21, 2026
The Logan, Philadelphia, USA
Register Now |
View Agenda |
Learn More